UBS AG - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 79 filers reported holding ANTARES PHARMA INC in Q3 2014. The put-call ratio across all filers is 37.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AG ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2014$11,000
-70.3%
5,900
-57.9%
0.00%
Q2 2014$37,000
-78.2%
14,000
-71.2%
0.00%
Q1 2014$170,000
-70.7%
48,600
-62.7%
0.00%
Q4 2013$581,000
+884.7%
130,150
+791.4%
0.00%
Q3 2013$59,000
-81.2%
14,600
-80.7%
0.00%
Q2 2013$314,00075,5370.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders